Phase 3
Completed N=66
Stopping Cavities Study: Diammine Silver Fluoride
Source: ClinicalTrials.gov NCT02536040 ↗Enrolled (actual)
66
Serious AEs
0.0%
Results posted
Jan 2020
Primary outcomePrimary: Dental Caries Activity — .72; .05 Proportion of arrested caries lesions
◆ Published Evidence
No publication linked
No peer-reviewed publication reporting this trial's results has been linked yet. This can indicate results are unpublished — a known publication-bias signal. We re-check periodically.
Summary
This study is being conducted to test whether the use of diammine silver fluoride (also called silver diamine fluoride) hardens the cavity sufficiently so that it arrests.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Dental Caries Activity |
.72; .05 | — |
Eligibility Criteria
Inclusion Criteria
- Nyvad criteria 3
- Active carious lesion
Exclusion Criteria
- Allergy to silver
- Stomatitis or oral ulcerative condition
- Weight less than 15 kg
Data sourced from ClinicalTrials.gov (NCT02536040). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.